Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - cisatracurium besilate -

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

as kalceks - cisatracurium besilate; cisatracurium - solution for injection/infusion - 2 milligram(s)/millilitre - cisatracurium

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - cisatracurium besilate -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - cisatracurium besilate, quantity: 0.669 % w/v - solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - cisatracurium besilate, quantity: 0.268 % w/v - solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - cisatracurium besilate, quantity: 0.268 % w/v - solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - cisatracurium besilate, quantity: 0.268 % w/v - solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - cisatracurium besilate -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - cisatracurium besilate -

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

as kalceks - atracurium besilate - solution for injection/infusion - 10 milligram(s)/millilitre - other quaternary ammonium compounds; atracurium